Episode Details

Back to Episodes
Leadership in the US vs. Europe and Launching a Rare Disease Drug

Leadership in the US vs. Europe and Launching a Rare Disease Drug

Published 3 years, 6 months ago
Description
In episode 121 of the Pharm Exec Podcast, Nathalie Dompé, co-CEO of Dompé Pharmaceuticals, shares a glimpse into her journey in the pharma industry, her leadership style, the differences in working in leadership in the United States vs. Europe (Italy, specifically), and technologies in the biopharma industry. Meg Rivers, editor-in-chief, and Miranda Schmalfuhs, group social media editor, also talk to Dompé about: 1) launching a rare disease drug in the United States, the commercial/sales/marketing challenges, and what the company learned in the process; 2) how launching a rare disease drug differs from other drugs as it relates to the commercialization phase; 3) how can the industry can best meet the needs of patients and health systems; 4) balancing family/home life and work.
Listen Now

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us